Published in J Pediatr on April 01, 1979
Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol (1980) 13.49
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
The genus Campylobacter: a decade of progress. Clin Microbiol Rev (1988) 5.49
Campylobacter enteritis. Can Med Assoc J (1979) 5.14
Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev (1998) 4.39
Broiler chickens as potential source of Campylobacter infections in humans. J Clin Microbiol (1980) 4.03
Investigation of a Campylobacter jejuni outbreak by serotyping and chromosomal restriction endonuclease analysis. J Clin Microbiol (1984) 3.54
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Experimental Campylobacter diarrhea in chickens. Infect Immun (1981) 2.88
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother (1980) 2.38
Campylobacter enteritis in general practice. J Hyg (Lond) (1982) 2.24
Occurrence of plasmid DNA in serologically defined strains of Campylobacter jejuni and Campylobacter coli. Infect Immun (1983) 2.18
Intestinal colonization of neonatal animals by Campylobacter fetus subsp. jejuni. Infect Immun (1981) 2.00
Application of the Fortner principle to isolation of Campylobacter from stools. J Clin Microbiol (1979) 1.96
Serotyping of Campylobacter jejuni isolated from sporadic cases and outbreaks in British Columbia. J Clin Microbiol (1982) 1.86
Enrichment medium and control system for isolation of Campylobacter fetus subsp. jejuni from stools. J Clin Microbiol (1982) 1.83
Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media. J Clin Microbiol (1985) 1.65
Two cases of Campylobacter mucosalis enteritis in children. J Clin Microbiol (1993) 1.52
Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J Clin Microbiol (1986) 1.48
Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother (1987) 1.34
Enteritis associated with Campylobacter laridis. J Clin Microbiol (1987) 1.29
Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J Clin Microbiol (1988) 1.27
Campylobacter enteritis in Denver. West J Med (1982) 1.23
Extended scheme for serotyping Campylobacter jejuni: results obtained in Israel from 1980 to 1981. J Clin Microbiol (1983) 1.22
Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimens. J Clin Microbiol (1989) 1.18
Bacteraemia caused by Campylobacter spp. J Clin Pathol (1994) 1.17
Age related susceptibility to Campylobacter jejuni infection in a high prevalance population. Arch Dis Child (1983) 1.12
Isolation of Campylobacter fetus subsp. jejuni from human fecal specimens by incubation at 35 and 42 degrees C. J Clin Microbiol (1982) 1.11
Detection of campylobacter by immunofluorescence in stools and rectal biopsies of patients with diarrhoea. J Clin Pathol (1984) 1.10
Campylobacter enteritis associated with undercooked barbecued chicken. Am J Public Health (1984) 1.10
Comparison of basal media for culturing Campylobacter jejuni and Campylobacter coli. J Clin Microbiol (1985) 1.09
Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol (1988) 1.09
Investigation of a waterborne outbreak of Campylobacter jejuni enteritis with a serotyping scheme based on thermostable antigens. J Clin Microbiol (1983) 1.06
Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals. J Clin Microbiol (1985) 1.05
Characterization of freshly isolated Campylobacter coli strains and suitability of selective media for their growth. J Clin Microbiol (1988) 1.05
Neonatal campylobacter enteritis. Can Med Assoc J (1980) 1.01
Rate of Campylobacter spp. isolation in three regions of Ontario, Canada, from 1978 to 1985. J Clin Microbiol (1986) 0.98
Long-term infections with Campylobacter fetus subsp. jejuni. J Clin Microbiol (1981) 0.97
Persistent excretion of Campylobacter fetus subsp. jejuni. Can Med Assoc J (1981) 0.96
Serotype distribution of Campylobacter jejuni and Campylobacter coli isolated from hospitalized patients with diarrhea in central Australia. J Clin Microbiol (1992) 0.94
High prevalence of campylobacter excretors among Liberian children related to environmental conditions. Epidemiol Infect (1988) 0.94
Immune response of athymic and euthymic germfree mice to Campylobacter spp. Infect Immun (1986) 0.90
Infectious diarrhea: clinical implications of recent research. Can Med Assoc J (1980) 0.90
Dark-field microscopy of human feces for presumptive diagnosis of Campylobacter fetus subsp. jejuni enteritis. J Clin Microbiol (1982) 0.89
Systematic investigation of enrichment media for wild-type Campylobacter jejuni strains. J Clin Microbiol (1984) 0.87
Effect of ferrous sulfate, sodium metabisulfite, and sodium pyruvate on survival of Campylobacter jejuni. J Clin Microbiol (1983) 0.87
Management of diarrhea in infants and children. Can Fam Physician (1987) 0.86
Isolation of Campylobacter jejuni from an appendix. J Clin Microbiol (1983) 0.86
Approach to a Child with Colitis. Indian J Pediatr (2016) 0.84
Biotype and serogroup distribution of Campylobacter isolates from children in Nigeria. J Clin Microbiol (1986) 0.82
Campylobacter enteritis in the community. Br Med J (Clin Res Ed) (1983) 0.81
Gastrointestinal bleeding in the pediatric patient. Yale J Biol Med (1984) 0.80
Campylobacter enterocolitis: general and surgical aspects. Postgrad Med J (1986) 0.80
Acute encephalopathy associated with campylobacter enteritis. Br Med J (Clin Res Ed) (1986) 0.79
Susceptibility of Shigella species to erythromycin. Antimicrob Agents Chemother (1982) 0.79
Campylobacter Enteritis. Infection (1982) 0.78
Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario. Can J Infect Dis Med Microbiol (2013) 0.77
Campylobacter ileocolitis: an inflammatory bowel disease. Can Med Assoc J (1979) 0.77
Treatment of Campylobacter gastroenteritis. Arch Dis Child (1987) 0.77
Erythromycin-resistant Campylobacter jejuni. Can Med Assoc J (1980) 0.75
Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment. J Community Hosp Intern Med Perspect (2012) 0.75
Feasible method for routine surveillance culturing of stools from neutropenic patients. J Clin Microbiol (1984) 0.75
Campylobacter colitis--a cause of chronic diarrhea in children. West J Med (1982) 0.75
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet (1983) 10.11
Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63
Campylobacter enteritis. Can Med Assoc J (1979) 5.14
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16
Spontaneous mutant with loss of beta-lactamase in Aerobacter cloacae. J Bacteriol (1969) 3.57
Characteristics of Aerobacter beta-lactamase. Can J Microbiol (1968) 3.28
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol (1985) 2.70
Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56
The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol (1988) 2.51
Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet (1983) 2.44
Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother (1980) 2.38
The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J Infect Dis (1983) 2.17
Application of the Fortner principle to isolation of Campylobacter from stools. J Clin Microbiol (1979) 1.96
Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94
Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol (1991) 1.88
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Attempts to transmit campylobacter enteritis to dogs and cats. Can Med Assoc J (1978) 1.66
Direct isolation of atypical thermophilic Campylobacter species from human feces on selective agar medium. J Clin Microbiol (1989) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem (1991) 1.53
Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet (1988) 1.46
Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic. J Clin Microbiol (1998) 1.45
Campylobacter pyloridis is associated with acid-peptic disease in Toronto. Can J Surg (1986) 1.42
Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol (2000) 1.37
Antigenic heterogeneity of Escherichia coli verotoxins. Lancet (1986) 1.35
From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J Infect Dis (1988) 1.34
Human Escherichia coli O157:H7 infection associated with the consumption of unpasteurized goat's milk. Epidemiol Infect (1997) 1.34
Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis (1986) 1.22
Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Pediatr Infect Dis (1985) 1.19
Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2001) 1.18
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Mycoplasma pneumoniae as a determinant of the Guillain-Barré syndrome. Lancet (1969) 1.17
Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun (1997) 1.12
Transmissible tetracycline resistance in Campylobacter jejuni. Lancet (1980) 1.12
Pathogenesis of haemolytic uraemic syndrome. Lancet (1987) 1.12
Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am J Physiol (1997) 1.10
Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin. J Pediatr (1982) 1.09
Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse. Lancet (1988) 1.08
Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus. Lancet (1987) 1.07
Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr (1996) 1.07
Acute bacterial meningitis in childhood: an outline of management. Clin Pediatr (Phila) (1972) 1.06
Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect Immun (1994) 1.04
Inhibition of Aerobacter cephalosporin beta-lactamase by penicillins. J Bacteriol (1969) 1.01
Neonatal campylobacter enteritis. Can Med Assoc J (1980) 1.01
Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood (1995) 1.01
A family outbreak of hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli serotype O157:H7. Pediatr Nephrol (1988) 0.97
Heterogeneity in phenotypic and genotypic characteristics among strains of Hafnia alvei. J Clin Microbiol (1996) 0.93
Utility of gram stain in evaluation of sputa from patients with cystic fibrosis. J Clin Microbiol (1994) 0.93
Reinfection with Campylobacter jejuni. Lancet (1981) 0.92
Infection caused by Yersinia enterocolitica serotype O:21. J Clin Microbiol (1982) 0.92
Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J Infect Dis (1998) 0.92
Hemolytic-uremic syndrome--an outbreak in Sacramento, California. West J Med (1986) 0.91
Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1. J Clin Microbiol (1997) 0.91
Ampicillin in the treatment of bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1966) 0.90
Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol (1990) 0.89
Use of an ammonia electrode to study bacterial deamination of amino acids with special reference to D-asparagine breakdown by campylobacters. J Hyg (Lond) (1984) 0.87
Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol (1997) 0.86
Febrile mucocutaneous syndrome with respiratory involvement, associated with isolation of Mycoplasma pneumoniae. Can Med Assoc J (1967) 0.85
Effects of cycloheximide and puromycin on cytotoxic activity of Escherichia coli verocytotoxin (Shiga-like toxin). J Clin Microbiol (1987) 0.83
O-serotyping Providencia alcalifaciens. J Clin Microbiol (1979) 0.83
Campylobacter enterocolitis. Ann Intern Med (1979) 0.82
Acute cerebellar ataxia and concomitant infection with Mycoplasma pneumoniae. J Pediatr (1972) 0.82
Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. Infect Immun (1997) 0.82
The protean manifestattions of mycoplasma infections in childhood. Can Med Assoc J (1968) 0.81
Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid. Can J Microbiol (2002) 0.80
Modified ammonia electrode method to investigate D-asparagine breakdown by Campylobacter strains. J Clin Microbiol (1986) 0.79
The use of cephalosporin C in the identification of Enterobacteriaceae. Postgrad Med J (1970) 0.79
The nephrotoxic effect of cephaloridine. Postgrad Med J (1967) 0.78
Campylobacter ileocolitis: an inflammatory bowel disease. Can Med Assoc J (1979) 0.77
Cephaloridine and the penicillins in the treatment of staphylococcal osteomyelitis and arthritis. Postgrad Med J (1970) 0.76
Risk factors for infection with verocytotoxigenic Escherichia coli in cattle on Ontario dairy farms. Prev Vet Med (1998) 0.76
Erythromycin-resistant Campylobacter jejuni. Can Med Assoc J (1980) 0.75
Meningococcal osteomyelitis. Can Med Assoc J (1981) 0.75
Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole. Infection (1988) 0.75
Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome. Acta Paediatr Jpn (1995) 0.75
Anti-verocytotoxin (VT)1, VT2 and VT2c antibodies in commercial intravenous immune globulins in Japan. Acta Paediatr Jpn (1996) 0.75
Antibiotic chemotherapy in infections: problem of multiple resistance. Hosp Top (1975) 0.75
Campylobacter enterocolitis in a neonatal nursery. J Infect Dis (1984) 0.75
Susceptibility of Campylobacter species to niridazole. Eur J Clin Microbiol (1986) 0.75
Round table: optimal duration of antibiotic therapy in severe bacterial infections. Antimicrob Agents Chemother (Bethesda) (1967) 0.75
Miniaturization of leukocyte bactericidal function tests. Proc Soc Exp Biol Med (1973) 0.75